Pharmafile Logo

16 Generation Now

The impact of the millennial healthcare professional on our world

We believe that pharma companies have a choice
to make: they can either be commodity-based manufacturers of pills, or they can be partners to patients and physicians in the design of better treatment journeys. And, in the age of the socially conscious, there is only one choice for sustainable success.

Healthcare is in an age of transformation, with new science, new technology, new funding models and newly empowered patients. But at the heart of this transformation will be the millennial healthcare professionals (mHCPs). They exhibit different behaviours, different triggers and different ambitions, which must be understood by pharma if the true benefits of their progress are to be realised.

In this paper we will discuss the changes in society that are transforming physicians, and how we as an industry can best evolve to support stakeholders, improve outcomes and build brands.

This paper draws on in-depth interviews conducted by Havas Lynx with leading mHCPs, as well as with medical students, academics, technologists, prosumer patients and entrepreneurs from around the world, including the EU, North America and Asia.

This content was provided by Havas Lynx

Documents for download:

Company Details

 Latest Content from  Havas Lynx 

Havas Lynx Group elevates Jon Chapman and Paul Kinsella to CCOs

Havas Lynx Group announces the promotion of Jon Chapman and Paul Kinsella from Executive Creative Directors (ECD) to Chief Creative Officers (CCO) for Havas Lynx Group.

Elizabeth Egan appointed President of Havas Lynx Group

Europe’s largest healthcare communications agency has appointed a new President to help it build on a record year.

Havas Lynx Group lifts a silver Cannes Lion with landmark HIV campaign

Communicating a landmark moment for the HIV community has helped a leading healthcare communications agency secure another award at the famous Cannes Lions International Festival of Creativity.

Patient Centricity On Trial

Today, 40 million patients are needed for over 300,00 clinical trials, worldwide. This year’s white paper explores how bringing the patient experience front and centre in clinical trials could revolutionise...

19 Patient Centricity on Trial

Clinical trials are broken and only patients can help us fix them. If we let them.